Abstract
Purpose. Drug disposition is often altered in inflammatory disease. Although the influence of inflammation on hepatic drug metabolism and protein binding has been well studied, its impact on drug transport has largely been overlooked. The multidrug resistance (MDR) gene product, P-glycoprotein (P-gp) is involved in the active secretion of a large variety of drugs. Our goal was to ascertain the influence of acute inflammation (AI) on the expression and functional activity of P-gp.
Methods. AI was induced in rats through turpentine or lipopolysaccharide (LPS) administration. Expression of P-gp in liver was detected at the level of protein on Western blots using the monoclonal antibody C-219 and at the level of mRNA using an RNase protection assay. P-gp mediated transport activity was assessed by measuring the verapamil-inhibitable efflux of rhodamine 123 (R123) in freshly isolated hepatocytes.
Results. Turpentine-induced AI significantly decreased the hepatic protein expression of P-gp isoforms by 50−70% and caused a significant 45−65% reduction in the P-gp mediated efflux of R123. Diminished mRNA levels of all three MDR isoforms were seen. LPS-induced AI similarly resulted in significantly reduced levels and activity of P-gp in liver. Although differences in the constitutive levels of P-gp were seen between male and female rats, the influence of AI on P-gp expression and activity was not gender specific.
Conclusions. Experimentally-induced inflammation decreases the in vivo expression and activity of P-gp in liver. This is the first evidence that expression of P-gp is modulated in response to experimentally-induced inflammation.
Similar content being viewed by others
REFERENCES
R. E. Schneider, J. Babb, H. Bishop, and M. Mitchard. Plasma levels of propranolol in treated patients with coeliac disease and patients with Crohn's disease. Br. Med. J. 2:794–795 (1976).
F. M. Belpaire, F. De Smet, B. Chindavijak, N. Fraeyman, and M. G. Bogaert. Effect of turpentine-induced inflammation on the disposition kinetics of propranolol, metoprolol, and antipyrine in the rat. Fund. Clin. Pharmacol. 3:79–88 (1989).
M. Piquette-Miller and F. Jamali. Selective effect of adjuvant arthritis on the disposition of propranolol enantiomers in rats. Pharm. Res. 10:294–299 (1993).
Acute Phase Proteins: molecular biology, biochemistry & clinical Applications (A. Mackiewicz & I. Krushner, eds.), CRC Press Inc., Boca Raton, (1993).
E. T. Morgan. Suppression of constitutive P450 gene expression in livers of rats undergoing an acute phase response to endotoxin. Mol. Pharmacol. 36:699–707 (1989).
K. A. Walker, H. Barber, and G. Hanksworth. Mechanism responsible for altered propranolol disposition in adjuvant-induced arthritis in the rat. Drug Metab. Dispos. 14:482–486 (1986).
S. E. Kane, I. Pastan, and M. M. Gottesman. Mini-review: genetic basis of multidrug resistance of tumor cells. J. Bioenerg. Biomem. 22:593–618 (1990).
P. F. Juranka, R. L. Zastawny, and V. Ling. P-glycoprotein: multidrug-resistance and a superfamily of membrane-associated transport proteins. FASEB. 3:2583–92 (1989).
J. J. M. Smit, A. H. Schninkel, R. P. Elferink et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75:451–462 (1993).
T. W. Gant, J. A. Silverman, H. C. Bisgaard, R. K. Burt, P. A. Marino, and S. S. Thorgeirsson. Regulation of 2-acetylaminofluorene-and 3-methylcholanthrene-mediated induction of multidrug resistance and cytochrome P450 1A gene family expression in primary hepatocyte cultures and rat liver. Mol. Carcin. 4:499–59 (1991).
K. V. Chin, S. Tanaka, G. Darlington, I. Pastan, and M. M. Gottesman. Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. J. Biol. Chem. 265:221–226 (1990).
B. T. Hill, K. L. Deuchars, L. K. Hosking, V. Ling, and R. D. Whelan. Overexpression of P-glycoprotein in mammalian tumor cells lines after fractionated X irradiation in vitro. J. Natl. Cancer Inst. 82:607–612 (1990).
G. Schreiber, A. R. Aldred, T. Thomas et al. Levels of mRNA for plasma proteins in rat liver during acute experimental inflammation. Inflammation 10:59–67 (1986).
J. Milland, A. Tsykin, T. Thomas, A. R. Aldred, T. Cole, and G. Schreiber. Gene expression in regenerating and acute-phase rat liver. Am. J. Physiol. 259:G340–7 (1990).
G. Fantuzzi and C. A. Dinarello. The inflammatory response in IL-1-β-deficient mice: comparison with other cytokine-related knock-out mice. J. Leukocyte Biol. 59:489–93 (1996).
P. Moldeus, J. Hogberg, and S. Orrenius. Isolation and use of liver cells. Methods Enzymol. 52:60–70 (1978).
P. C. Brown, S. S. Thorgeirsson, and J. A. Silverman. Cloning and regulation of the rat mdr2 gene. Nucleic Acids Res. 21:3885–91 (1993).
E. Chieli, E. Santoni Rugiu, F. Cervelli, A. Paolicchi, and R. Tongiani. Assessment of P-glycoprotein dependent drug transport in isolated rat hepatocytes using rhodamine 123. Cell Biol. Toxicol. 9:235–42 (1993).
A. H. Schinkel, U. Mayer, E. Wagenaar et al. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc. Natl. Acad. Sci. USA 94:4028–33 (1997).
E. T. Morgan, K. B. Thomas, R. Swanson, T. Vales, J. Hwang, and K. Wright. Selective suppression of cytochrome P450 gene expression by IL-1 and IL-6 in rat liver. Biochim. Biophys. Acta 1219:475–483 (1994).
M. Trauner, M. Arrese, C. J. Soroka et al. The rat canalicular conjugate export pump (Mrp2) is downregulated in intrahepatic and obstructive cholestasis. Gastroent. 113:255–264 (1997).
H-D. Flad, H. Loppnow, E. T. Rietschel, and A. J. Ulmer. Agonists and antagonists for lipopolysaccharide-induced cytokines. Immunobiol. 187:303–316 (1993).
W. Walther and U. Stein. Influence of cytokines on mdr1 expression in human colon carcinoma cell lines: increased cytotoxicity of MDR relevant drugs. J. Cancer Res. Clin. Oncol. 120:471–478 (1994).
N. J. Combates, R. W. Rzepka, Y. N. P. Chen, and D. Cohen. NF-IL6, a member of the C/EBP family of transcription factors, binds and trans-activates the human mdr1 gene promoter. J.Biol. Chem. 269:29715–9 (1994).
J. J. M. Smit, C. A. Mol, L. Van Deemter, E. Wagenaar, A. H. Schninkel, and P. Borst. Characterization of the promoter region of the human MDR3 P-glycoprotein gene. Biochim. Biophys. Acta. 1261:44–56 (1995).
C. H. Lee, G. Bradley, and V. Ling. Overexpression of the class II P-glycoprotein gene in primary rat hepatocyte culture: evidence for increased mRNA stability. Cell Growth & Differentiation 6:347–54 (1995).
J. Drach, A. Gsur, G. Hamilton et al. Involvement of P-gp in the transmembrane transport of IL-2, IL-4 and IFN-γ in normal human T-lymphocytes. Blood 88:1747–54 (1996).
E. G. Schuetz, W. T. Beck, and J. D. Schuetz. Modulators and substrates of P-glycoprotein and cytochrome P450 3A coordinately upregulate these proteins in human colon carcinoma cells. Mol. Pharmacol. 49:311–318 (1996).
K. N. Furuya, R. Gebhardt, E. G. Schuetz, and J. D. Schuetz. Isolation of rat p-glycoprotein3 cDNA: evidence for gender and zonal regulation of expression in the liver. Biochim. Biophys. Acta. 1219:636–644 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Piquette-Miller, M., Pak, A., Kim, H. et al. Decreased Expression and Activity of P-GIycoprotein in Rat Liver During Acute Inflammation. Pharm Res 15, 706–711 (1998). https://doi.org/10.1023/A:1011962818051
Issue Date:
DOI: https://doi.org/10.1023/A:1011962818051